| Literature DB >> 30315181 |
Xi Zou1,2, Lihua Kang1, Mei Yang1, Jian Wu1, Huaijin Guan3.
Abstract
DNA oxidative damage repair is strongly involved in the pathogenesis of age-related cataract (ARC). The sequence variants of in coding region of DNA repair genes have been shown to be associated with ARC. It is known that single nucleotide polymorphisms (SNPs) in the 3'-terminal untranslated region (3'-UTR) can alter the gene expression by binding with microRNAs (miRNAs). We hypothesize that SNP(s) in miRNA binding site of certain DNA oxidative damage repair genes might associate with ARC risk. We examined 10 miRNA binding SNPs in 3'-UTR of 7 oxidative damage genes and revealed the XPC- rs2229090 C allele was associated with nuclear type of ARC (ARNC) risk in Chinese population. The individuals with the variant G allele (CG and GG) of XPC- rs2229090 had higher XPC mRNA expression compared to individuals carrying CC genotype. The in vitro assay showed that luciferase reporter gene expression can be down regulated by hsa-miR-589-5p in cells transfected with rs2229090 C allele compared to G allele. These results suggested that the C allele of XPC-2229090 increase the risk with ARNC. The mechanism underlying might be due to the stronger interation of the C allele with hsa-miR-589-5p, resulting in lower XPC expression and DNA repair capability than the individuals carring G allele in lens.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30315181 PMCID: PMC6185952 DOI: 10.1038/s41598-018-33071-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Demographic Information of Study Participants.
| Variable | n | Age |
| Sex | χ2 |
| ||
|---|---|---|---|---|---|---|---|---|
| Mean ± SD | Range | Male (%) | Female (%) | |||||
| Controls | 993 | 69.80 ± 4.47 | 50–80 | 447 (45.0) | 546 (55.0) | |||
| ARCs | 993 | 69.72 ± 6.04 | 50–80 | 0.73 | 449 (45.2) | 544 (54.8) | 0.008 | 0.48 |
| C | 453 | 70.15 ± 5.64 | 52–80 | 0.45 | 201 (44.4) | 252 (55.6) | 0.052 | 0.52 |
| N | 276 | 68.98 ± 5.86 | 50–79 | 0.12 | 128 (46.4) | 148 (53.6) | 0.162 | 0.37 |
| P | 52 | 68.15 ± 4.16 | 50–78 | 0.09 | 24 (46.2) | 28 (51.58) | 0.026 | 0.49 |
| M | 212 | 70.14 ± 6.14 | 51–80 | 0.51 | 96 (45.1) | 116 (54.7) | 0.005 | 0.50 |
C: cortical; N: nuclear; P: posterior sub capsular cataract; M: mixed type.
The Included SNPs of the 3′-UTR of the Selected Genes.
| Gene name | Function in DNA repair | SNPs | Nucleotide change | MAF | miRNA binding |
|---|---|---|---|---|---|
|
| NER | rs3176752 | C > A | 0.10 | hsa-miR-4753–3p |
|
| NER | rs2229090 | C > G | 0.29 | hsa-miR-589-5p |
|
| DSBR | rs2241201 | G > C | 0.15 | hsa-miR-4731-3p |
| rs877710 | C > G | 0.25 | hsa-miR-564 | ||
| rs11067231 | C > A | 0.25 | hsa-miR-1972 | ||
| rs11067233 | C > G | 0.10 | hsa-miR-603 | ||
|
| DSBR | rs7310449 | A > G | 0.4 | hsa-miR-299-3p |
|
| DSBR | rs7301931 | C > T | 0.4 | hsa-miR-4322 |
|
| DSBR | rs2035990 | C > T | 0.5 | hsa-miR-567 |
|
| DSBR | rs2440 | C > T | 0.2 | hsa-miR-548ao-3p |
MAF: minor allele frequency in Chinese population.
Summary of Associations between the SNPs and ARC.
| Gene | SNPs | Controls | ARCs | χ2 |
| OR (95%CI) |
|---|---|---|---|---|---|---|
|
| rs3176752 | 1740/246 | 1751/235 | 0.286 | 0.592 | 0.95 |
|
|
| 1171/815 | 1305/681 | 19.255 |
| 0.75 |
|
| rs2241201 | 1560/426 | 1553/433 | 0.073 | 0.787 | 1.02 |
| rs877710 | 1343/643 | 1306/680 | 1.552 | 0.213 | 1.09 | |
| rs11067231 | 1350/636 | 1343/643 | 0.057 | 0.812 | 1.01 | |
| rs11067233 | 1736/250 | 1726/260 | 0.225 | 0.635 | 1.05 | |
|
| rs7310449 | 1191/795 | 1172/814 | 0.377 | 0.280 | 1.04 |
|
| rs7301931 | 1112/874 | 1096/890 | 0.261 | 0.316 | 1.03 |
|
| rs2035990 | 1003/983 | 1015/971 | 0.145 | 0.364 | 0.98 |
|
| rs2440 | 1589/397 | 1567/419 | 0.746 | 0.205 | 1.07 |
Pa: P value after Bonferroni correction.
Association between rs2229090 and the C, N, M Type of ARC.
| Gene/SNP | Allele | Control, n (%) | C Type of ARC, n (%) | N Type of ARC, n (%) | M Type of ARC, n (%) |
|---|---|---|---|---|---|
| C | 1171 (58.96) | 570 (62.91) | 389 (70.47) | 277 (65.33) | |
| G | 815 (41.04) | 336 (37.09) | 163 (29.53) | 147 (34.67) | |
| 0.044/0.44 |
| 0.008/0.08 | |||
| OR (95% CI) | 0.85 (0.72–0.99) | 0.60 (0.49–0.74) | 0.76 (0.61–0.95) |
Association Between rs2229090 and the N Type of ARC.
| Gene/SNP | Allele | Control, n (%) | N, n (%) | OR (95% CI) | |
|---|---|---|---|---|---|
| C | 1171 (58.96) | 376 (68.12) | <0.0001/<0.001 | 0.67 | |
| G | 815 (41.04) | 176 (31.88) | (0.55–0.82) | ||
| dominant model | CC | 356 (35.85) | 128 (46.38) | 0.0014/0.014 | 0.65 |
| CG + GG | 637 (64.15) | 148 (53.62) | (0.49–0.85) | ||
| recessive model | CC + CG | 815 (82.72) | 248 (89.86) | 0.0019/0.019 | 0.52 |
| GG | 178 (17.93) | 28 (10.14) | (0.34–0.79) |
Figure 1Levels of XPC mRNA expression in anterior capsules. (A) XPC mRNA levels were lower in ARNCs than the controls. (B) XPC mRNA levels were higher in CG or GG group than the CC group. *P < 0.05, **P < 0.01.
Figure 2Representative images of comet assay: (A) controls and (B) ARNCs. (C) DNA breaks measured by Comet assay in LECs and peripheral lymphocytes, ARNCs had more DNA breaks than the controls. (D) The correlation between lymphocytes and LECs in %Tail DNA and OTM. (E) the DNA damage between different genotypes showed no difference. *P < 0. 001. Scale bars: 50 μm.
DNA damage in LECs and lymphocytes of Controls and ARNCs.
| Group | Lymphocytes | LECs | ||
|---|---|---|---|---|
| %Tail DNA | OTM | %Tail DNA | OTM | |
| Controls | 9.05 ± 1.60* | 1.56 ± 0.44* | 2.39 ± 0.95* | 0.41 ± 0.15* |
| ARNCs | 21.18 ± 2.30 | 6.37 ± 1.03 | 9.97 ± 1.97 | 2.97 ± 0.69 |
LECs: lens epithelial cells. *P < 0.001 in comparison with the Controls.
Figure 3The effect of hsa-miR-589-5p on miRSNP rs2229090. (A) Constructs of different alleles of miRNA-binding sites. (B) MiR-589-5p mimics or inhibiters were co-transfected with the reporter constructs containing C allele or G allele into SRA01/04 cells. *P < 0.05, compared with G allele group. (C) Levels of XPC mRNA expression of the SRA01/04 cells transfected with hsa-miR-589-5p mimics or inhibitors. *P < 0.05, compared with control group.